Dr. Narendra Agrawal: Consultant Hemato Oncology & Bone Marrow Transplant Delhi

Dr. Narendra Agrawal

MBBS, MD, DM (Hematology)

Senior Consultant Department of Hemato-Oncology & Bone Marrow Transplant

Book an Appointment

Rajiv Gandhi Cancer Institute, Sector - 5, Rohini, Delhi - 110 085

About

Dr Narendra Agrawal received hematology training since 2007 from SGPGI MS Lucknow and All India Institute of Medical Sciences (AIIMS) Delhi and was awarded DM in Clinical Hematology from AIIMS Delhi.
He is serving at Rajiv Gandhi Cancer Institute & Research Centre as consultant since January 2012 and has been involved in treatment of patients with blood cancers as well as common blood diseases like anemia, thalassemia and bleeding disorders.
He takes deep interest in academic activities, post graduate teachings and research work apart from clinical work. He has good number of scientific publications in reputed national and international journals. He has also presented his research work at international forums.
He is coordinator and a tutor for PICC training program and Bone Marrow Biopsy training program at RGCI.

Specialized Areas

Allogeneic bone marrow/ stem cell transplantation
Autologous bone marrow/ stem cell transplantation
Blood cancers like acute leukemia (AML, ALL), lymphoma, myeloma, myelodysplastic syndromes
Blood diseases like anemia, aplastic anemia, bleeding disorders (eg ITP), coagulation disorder (eg DVT)
Congenital blood disorders like Thalassemia and other hemoglobinopathies, Hemophilia

Educational Background

D.M. (Hematology): 2009-2011, All India Institute of Medical Sciences, Delhi
M.D.: 2000-2003, Jawahar Lal Nehru Medical College, Ajmer, Rajasthan (University of Rajasthan)
M.B.B.S: 1993-99, Ravindra Nath Tagore Medical College, Udaipur, Rajasthan (University of Rajasthan)

Experience

Clinical experience since year 2000
Experience in hematology and bone marrow transplantation since 2007
Teaching experience in clinical hematology since 2007
Research and clinical trials in such areas like AML, DVT, ALL, BMT, Lymphoma and Myeloma, ITP
Consultant in department of Hemato-oncology at Rajiv Gandhi Cancer Institute since January 2012

Professional Journey

PUBLICATION

Publications: His main area of research and publications has been acute lymphoblastic leukemia (ALL). From a large list of his research publications, few of notable publications till year 2020 are:

Kapoor J, Agrawal N, Ahmed R, Sharma SK, Gupta A, Bhurani D. Factors influencing adherence to imatinib in Indian chronic myeloid leukemia patients: a cross-sectional study. Mediterr J Hematol Infect Dis. 2015 Feb 20;7(1):e2015013. doi: 10.4084/MJHID.2015.013.
Agrawal N, Aggarwal M, Kapoor J, Ahmed R, Shrestha A, Kaushik M, Bhurani D. Incidence and clinical profile of tuberculosis after allogeneic stem cell transplantation. Transplant Infectious Disease. 2018 Feb;20(1):e12794.
Aggarwal M, Agrawal N, Yadav N, Verma P, Ahmed R, Mehta P, Kapoor J, Bhurani D. Autologous stem cell transplantation in first remission is associated with better progression-free survival in multiple myeloma. Annals of Hematology. 2018 May 21:1-9.
Agrawal N, Verma P, Yadav N, Ahmed R, Mehta P, Soni P, Francis S, Bhurani D. Outcome of Philadelphia Positive Acute Lymphoblastic LeukemiaWith or Without Allogeneic Stem Cell Transplantation in a Retrospective Study. Indian J Hematol Blood Transfus. 2019 Apr 12;35(2):240-7.
Agrawal N, Yadav N, Verma P, Soni P, Mehta P, Thekkudan SF, Ahmed R, Bhurani D. Study of Haploidentical Stem Cell Transplantation for Philadelphia/BCR-ABL Positive Acute Lymphoblastic Leukemia. Indian J Hematol Blood Transfus. 2019 Apr 12;35(2):357-9.
Kapoor J, Pramanik SK, Agrawal P, Khushoo V, Naim F, Mirgh SP, Ahmed R, Bhurani D, Agrawal N. Retrospective institutional analysis of fludarabine/8 Gy TBI reduced intensity conditioning in high risk ALL. Bone Marrow Transplantation. 2020 Apr 14:1-3
Vivek Radhakrishnan, Narendra Agrawal, Bhausaheb Bagal, Ishan Patel; Systematic Review of the Burden and Treatment Patterns of Adult and Adolescent Acute Lymphoblastic Leukemia in India: Comprehending the Challenges in an Emerging Economy. Clinical Lymphoma, Myeloma and Leukemia (2020), doi: https://doi.org/10.1016/j.clml.2020.08.023